REE:NASDAQREE Automotive Ltd. Analysis
Data as of 2026-05-19 - not real-time
$0.42
Latest Price
8/10Risk
Risk Level: High
Executive Summary
REE Automotive is trading well below its short‑ and medium‑term moving averages, with the price sitting under the 20‑day, 50‑day and 200‑day SMA bands, underscoring a persistent bearish bias. The RSI is hovering in the low‑30s, suggesting the stock is technically oversold yet momentum remains weak, as confirmed by a bearish MACD histogram and a MACD line that sits beneath its signal line. Volatility is exceptionally high, exceeding 70% over the past 30 days, and the beta of roughly 1.3 signals amplified moves relative to the broader market, amplifying downside risk. Fundamentally, the company reports negative operating margins, substantial operating cash‑flow deficits and a debt‑to‑equity ratio above 280%, indicating a strained balance sheet with limited financial flexibility. No dividend is paid and the price‑to‑book ratio is well under one, reflecting a market perception of deep discount relative to book value, but the price‑to‑sales multiple remains elevated, hinting at overvaluation on a sales basis. The recent filing of a supplemental proxy statement for a special shareholders’ meeting adds a layer of governance uncertainty that could affect investor confidence. Coupled with a “Extreme Greed” sentiment reading, the market appears eager despite the company’s precarious fundamentals, creating a classic high‑risk, low‑reward scenario.
Given the confluence of bearish technical signals, deteriorating financial health, high volatility, and elevated sector and liquidity risks, the outlook remains decidedly negative. Investors should weigh the substantial downside potential against any speculative upside from a potential turnaround, which appears unlikely without significant capital infusion or strategic partnership. Caution is advised, and any exposure should be limited to a small, speculative portion of a diversified portfolio.
Given the confluence of bearish technical signals, deteriorating financial health, high volatility, and elevated sector and liquidity risks, the outlook remains decidedly negative. Investors should weigh the substantial downside potential against any speculative upside from a potential turnaround, which appears unlikely without significant capital infusion or strategic partnership. Caution is advised, and any exposure should be limited to a small, speculative portion of a diversified portfolio.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 9/10
Key Factors
- Price below all major moving averages
- Bearish MACD and low RSI
- Elevated volatility and beta
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Continued negative cash flow and high debt load
- Uncertain governance after special shareholders’ meeting
- Lack of dividend and weak earnings outlook
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential upside if the company secures strategic partnerships or financing
- Low price‑to‑book may offer marginal value if turnaround occurs
- Persistent sector cyclicality and competitive pressure
Key Metrics & Analysis
Financial Health
Revenue Growth4537.50%
P/E Ratio-0.2
ROE-373.57%
ROA-78.96%
Debt/Equity283.87
P/B Ratio0.3
Op. Cash Flow$-68710000
Free Cash Flow$-63804248
Technical Analysis
TrendBearish
RSI33.4
Support$0.40
Resistance$0.61
MA 20$0.49
MA 50$0.56
MA 200$0.72
MACDBearish
VolumeIncreasing
Fear & Greed Index89.2
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta1.32
Volatility71.87%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.